Nothing Special   »   [go: up one dir, main page]

Abbate et al., 1998 - Google Patents

Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagen

Abbate et al., 1998

View HTML
Document ID
14212711180176751137
Author
Abbate M
Kalluri R
Corna D
Yamaguchi N
McCluskey R
Hudson B
Andres G
Zoja C
Remuzzi G
Publication year
Publication venue
Kidney international

External Links

Snippet

Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagen. Background Glomerulonephritis and lung hemorrhage of autoimmune Goodpasture syndrome develop due to immune reactions against epitope (s) of the non …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Abbate et al. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagen
US11000566B2 (en) Compositions and methods for modulating the immune system
Kalluri et al. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.
Cooke et al. The pathogenesis of chronic inflammation in experimental antigen-induced arthritis: II. Preferential localization of antigen-antibody complexes to collagenous tissues
Kim et al. Differential expression of basement membrane collagen chains in diabetic nephropathy.
Neumann et al. Induction of multiple heart autoantibodies in mice with coxsackievirus B3-and cardiac myosin-induced autoimmune myocarditis.
JP4052524B2 (en) Ligand for induction of antigen-specific apoptosis in T cells
Strober et al. MATURATION OF B LYMPHOCYTES IN THE RAT: I. Migration Pattern, Tissue Distribution, and Turnover Rate of Unprimed and Primed B Lymphocytes Involved in the Adoptive Antidinitrophenyl Response
Winn et al. Acute destruction by humoral antibody of rat skin grafted to mice: the role of complement and polymorphonuclear leukocytes
US6048529A (en) PVA or PEG conjugates of peptides for epitope-specific immunosuppression
JPH09509053A (en) T-cell antigens and their use in the diagnosis and treatment of T-cell mediated conditions
Kleppel et al. Immunochemical studies of the Alport antigen
Flechner Cyclosporine: a new and promising immunosuppressive agent
JPH06500173A (en) Methods and compositions for early detection and treatment of insulin-dependent diabetes mellitus
Aten et al. Antigenic specificities of glomerular-bound autoantibodies in membranous glomerulopathy induced by mercuric chloride
KR100333148B1 (en) Soluble T-cell receptor α chains and derivatives containing Vα 14Jα 281 used as a preventive and therapeutic agent for diabetes diseases
Pusey et al. Autoimmunity in rapidly progressive glomerulonephritis
Neale et al. Spontaneous glomerulonephritis in rabbits: role of a glomerular capillary antigen
Guella et al. Idiopathic membranous nephropathy in identical twins
Lou et al. Altered target organ. A mechanism of postrecovery resistance to murine autoimmune oophoritis.
Govallo Immunology of pregnancy and cancer
Feucht et al. Detection of both isotypes of complement C4, C4A and C4B, in normal human glomeruli
CA2486545A1 (en) Peptides capable of modulating immune response
Bolton et al. Goodpasture's epitope in development of experimental autoimmune glomerulonephritis in rats
Luo et al. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats